Monocytes influence the fate of T cells challenged with oxidised low density lipoproteins towards apoptosis or MHC-restricted proliferation

Atherosclerosis

Volumn 156, Issue 1, 2001, Pages 11-21

  Fortun, Axelle ^a,b   Khalil, Abdelouahed ^a   Gagné, Danièle ^a   Douziech, Nadine ^a   Kuntz, Christelle ^a   Jay Gerin, Jean Paul ^b   Dupuis, Gilles ^c   Fülöp Jr, Tamàs ^a,b  

^a UNIVERSITY INSTITUTE OF GERIATRICS OF SHERBROOKE   (Canada)

^b UNIVERSITÉ DE SHERBROOKE   (Canada)

^c UNIVERSITY OF SHERBROOKE   (Canada)

Author keywords

Antigen presentation; Apoptosis; Atherosclerosis; Human; Low density lipoproteins; Monocytes; T lymphocytes

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; FUCOIDIN; HLA DR ANTIGEN; LOW DENSITY LIPOPROTEIN;

ANTIGEN PRESENTATION; APOPTOSIS; ARTERY LESION; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CELL PROLIFERATION; CELL STIMULATION; CELL SURVIVAL; CONTROLLED STUDY; HUMAN; HUMAN CELL; MAJOR HISTOCOMPATIBILITY COMPLEX; MONOCYTE; OXIDATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIOLYSIS; T LYMPHOCYTE;

ADULT; ANTIGENS, CD; ANTIGENS, CD80; ANTIGENS, CD86; APOPTOSIS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL DIVISION; CHEMOTAXIS, LEUKOCYTE; HLA-DR ANTIGENS; HUMANS; LIPOPROTEINS, LDL; MAJOR HISTOCOMPATIBILITY COMPLEX; MEMBRANE GLYCOPROTEINS; MONOCYTES; POLYSACCHARIDES; T-LYMPHOCYTES;

EID: 0035021877     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(00)00575-X     Document Type: Article

References (63)

1. Ross R. Cell biology of atherosclerosis. Ann. Rev. Physiol. 57:1995;791.
2. Steinberg D. Low density lipoprotein oxidation and its pathobiological significance. J. Biol. Chem. 272:1997;20963.
3. Watanabe T, Haraoka S, Shimokama T. Inflammatory and immunological nature of atherosclerosis, Int J Cardiol 1996; 54, Suppl. S25.
4. Haraoka S., Shimokama T., Watanabe T. Participation of T lymphocytes in atherogenesis: sequential and quantitative observation of aortic lesions of rats with diet-induced hypercholesterolaemia using en face double immunostaining. Virchows Arch. 426:1995;307.
5. McMurray H.F., Parthasarathy S., Steinberg D. Oxidatively modified low density lipoprotein is a chemoattractant for human T lymphocytes. J. Clin. Invest. 92:1993;1004.
6. Wissler RW. PDAY Group: Atheroarteritis: A combined immunological and lipid imbalance, Int J Cardiol 1996; 54, Suppl. S37.
7. Libby P., Hansson G.K. Involvement of the immune system in human atherogenesis: current knowledge and unanswered questions. Lab. Invest. 64:1991;5.
8. Hansson G.K., Seifert P.S., Olsson G., Bondjers G. Immunohistochemical detection of macrophages and T lymphocytes in atherosclerotic lesions of cholesterol-fed rabbits. Arterioscler. Thromb. Vasc. Biol. 11:1991;745.
9. Stemme S., Holm J., Hansson G.K. T lymphocytes in human atherosclerotic plaques are memory cells expressing CD45RO and the integrin VLA-1. Arterioscler. Thromb. Vasc. Biol. 12:1992;206.
10. Schmitz G., Herr A.S., Rothe G. T-lymphocytes and monocytes in atherogenesis. Herz. 23:1998;168.
11. Van der Wal A.C., Piek J.J., De Boer O.J., Koch K.T., Teeling P., Van der Loos C.M., Becker A.E. Recent activation of the plaque immune response in coronary lesions underlying acute coronary syndromes. Heart. 80:1998;14.
12. Rekhter M.D., Gordon D. Active proliferation of different cell types, including lymphocytes, in human atherosclerotic plaques. Am. J. Pathol. 147:1995;668.
13. Hansson G.K., Jonasson L., Lojsthed B., Stemme S., Kocher O., Gabbiani G. Localization of T lymphocytes and macrophages in fibrous and complicated human atherosclerotic plaques. Atherosclerosis. 72:1988;135.
14. Jonasson L., Holm J., Skalli O., Gabbiani G., Hansson G.K. Expression of class II transplantation antigen on vascular smooth muscle cells in human atherosclerosis. J. Clin. Invest. 76:1985;125.
15. de Boer O.J., Hirsch F., van der Wal A.C., van der Loos C.M., Das P.K., Becker A.E. Costimulatory molecules in human atherosclerotic plaques: An indication of antigen specific T lymphocyte activation. Atherosclerosis. 133:1997;227.
16. Frostegård J., Wu R., Giscombe R., Holm G., Lefvert A.K., Nilsson J. Induction of T-cell activation by oxidized low density lipoprotein. Arterioscler. Thromb. Vasc. Biol. 12:1992;461.
17. Kishikawa H., Shimokama T., Watanabe T. Localization of T lymphocytes and macrophages expressing IL-1, IL-2 receptor, IL-6 and TNF in human aortic intima. Role of cell-mediated immunity in human atherogenesis. Virchows Arch. A. 423:1993;433.
18. Dalekos G.N., Elisaf M., Bairaktari E., Tsolas O., Siamopoulos K.C. Increased serum levels of interleukin-1β in the systemic circulation of patients with essential hypertension: Additional risk factor for atherogenesis in hypertensive patients? J. Lab. Clin. Med. 129:1997;300.
19. Huang Y.H., Ronnelid J., Frostegard J. Oxidized LDL induces enhanced antibody formation and MHC class II-dependent IFN-gamma production in lymphocytes from healthy individuals. Arterioscler. Thromb. Vasc. Biol. 15:1995;1577.
20. Salonen J.T., Ylä-Herttuala S., Yamamoto R., Butler S., Korpela H., Salonen R., Nyyssönen K., Palinski W., Witztum J.L. Autoantibody against oxidised LDL and progression of carotid atherosclerosis. Lancet. 339:1992;883.
21. Stemme S., Faber B., Holm J., Wiklund O., Witztum J.L., Hansson G.K. T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein. Proc. Natl. Acad. Sci. USA. 92:1995;3893.
22. + T-lymphocytes and their interleukin 2 receptor expression in vitro. Biochem. J. 330:1998;659-666.
23. Viora M., Straface E., di Genova G., Fattorossi A., Rivabene R., Camponeschi B., Masella R., Malorni W. Oxidized low density lipoproteins impair peripheral blood mononuclear cell proliferation and cytokine production. Biochem. Biophys. Res. Commun. 232:1997;359.
24. Nishio E., Arimura S., Watanabe Y. Oxidized LDL induces apoptosis in cultured smooth muscle cells: A possible role for 7-ketocholesterol. Biochem. Biophys. Res. Commun. 223:1996;413.
25. Reid V.C., Hardwick S.J., Mitchinson M.J. Fragmentation of DNA in P388D1 macrophages exposed to oxidised low-density lipoprotein. FEBS Lett. 332:1993;218.
26. Reid V.C., Mitchinson M.J., Skepper J.N. Cytotoxicity of oxidized low-density lipoprotein to mouse peritoneal macrophages: An ultrastructural study. J. Pathol. 171:1993;321.
27. Hardwick S.J., Hegyi L., Clare K., Law N.S., Carpenter K.L.H., Mitchinson M.J., Skepper J.N. Apoptosis in human monocyte-macrophages exposed to oxidized low density lipoprotein. J. Pathol. 179:1996;294.
28. Escargueil-Blanc I., Salvayre R., Nègre-Salvayre A. Necrosis and apoptosis induced by oxidized low density lipoproteins occur through two calcium-dependent pathways in lymphoblastoid cells. FASEB J. 8:1994;1075.
29. Han D.K. M, Haudenschild C.C., Hong M.K., Tinkle B.T., Leon M.B., Liau G. Evidence for apoptosis in human atherogenesis and in a rat vascular injury model. Am. J. Pathol. 147:1995;267.
30. Geng Y.J., Libby P. Evidence for apoptosis in advanced human atheroma. Colocalization with interleukin-1α-converting enzyme. Am. J. Pathol. 147:1995;251.
31. Björkerud S., Björkerud B. Apoptosis is abundant in human atherosclerotic lesions, especially in inflammatory cells (macrophages and T cells), and may contribute to the accumulation of gruel and plaque instability. Am. J. Pathol. 149:1996;367.
32. Cai W.J., Devaux B., Schaper W., Schaper J. The role of Fas/APO 1 and apoptosis in the development of human atherosclerotic lesions. Atherosclerosis. 131:1997;177.
33. Best P.J.M., Hasdai D., Sangiorgi G., Schwartz R.S., Holmes D.R., Simari R.D., Lerman A. Apoptosis - basic concepts and implications in coronary artery disease. Arterioscler. Thromb. Vasc. Biol. 19:1999;14.
34. Kockx M.M. Apoptosis in the atherosclerotic plaque-quantitative and qualitative aspects. Arterioscler. Thromb. Vasc. Biol. 18:1998;1519.
35. Kockx M.M., De Meyer G.Y., Buyssens N., Knaapen M.W.M., Bult H., Herman A.G. Cell composition, replication and apoptosis in atherosclerotic plaques after 6 months of cholesterol withdrawal. Circ. Res. 83:1998;378.
36. Kockx M.M., Demeyer G.Y., Muhring W., Jacob W., Bult H., Herman A.G. Apoptosis and related proteins in different stages of human atherosclerotic plaques. Circulation. 97:1998;2307.
37. Bennett J.J., Boyle M.R. Apoptosis of vascular smooth muscle cells in atherosclerosis. Atherosclerosis. 138:1998;3.
38. Khalil A., Wagner J.R., Lacombe G., Dangoisse V., Fülöp T. Jr. Increased susceptibility of low-density lipoprotein (LDL) to oxidation by γ-radiolysis with age. FEBS Lett. 392:1996;45.
39. Spinks JWT, Woods RJ. An Introduction to Radiation Chemistry, 3rd ed. New York: Wiley-Interscience, 1990.
40. Fülöp T. Jr., Leblanc C., Lacombe G., Dupuis G. Cellular distribution of protein kinase C isozymes in CD3-mediated stimulation of human T lymphocytes with aging. FEBS Lett. 375:1995;69.
41. Khalil A., LeHoux J.G., Wagner R.J., Lesur O., Cruz S., Dupont É., Jay-Gerin J.P., Wallach J., Fülöp Jr T. Dehydroepiandrosterone protects low density lipoproteins against peroxidation by free radicals produced by γ-radiolysis of ethanol-water mixtures. Atherosclerosis. 136:1998;99.
42. Engelman E.G., Benike C.J., Grumet F.C., Evans R.L. Activation of human T lymphocyte subsets: helper and suppressor/cytotoxic T cells recognize and respond to distinct histocompatibility antigens. J. Immunol. 127:1981;2124.
43. Fülöp Jr T., Fouquet C., Allaire P., Perrin N., Lacombe G., Stankova J., Rola-Pleszczynski M., Gagné D., Wagner J.R., Khalil A., Dupuis G. Changes in apoptosis of human polymorphonuclear granulocytes with aging. Mech. Age Dev. 96:1997;15.
44. Vermes I., Haanen C., Steffens-Nakken H., Reutelingsperger C. A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. J. Immunol. Methods. 184:1995;39.
45. Liles W.C., Dale D.C., Klebanoff S.J. Glucocorticoids inhibit apoptosis of human neutrophils. Blood. 86:1995;3181.
46. Sprague E.A., Edwards E.H., Valente A.J., Suenram C.A., Kerbacher J.J., Schwartz C.J. Low-density lipoprotein endocytosis. II. Influence of the multivalent ligand cationized ferritin on acetylated low-density lipoprotein endocytosis in cultured cells. Exper. Mol. Pathol. 48:1988;373.
47. Germain RN. Antigen Processing and Presentation, In: Paul WE, editor. Fundamental Immunology. 4th ed. New York: Lippincott-Raven, 1999. p. 287-340.
48. Stemme S., Hansson G.K. Immune mechanisms in atherosclerosis. Coron. Artery Dis. 5:1994;216.
49. Massy Z.A., Keane W.F. Pathogenesis of atherosclerosis. Sem. Nephrol. 16:1996;12.
50. Witztum JL. Immunological response to oxidized LDL, Atherosclerosis 1997; 131, Suppl. S9.
51. Miossec P., Cavender D., Ziff M. Interleukin 1 derived from human endothelial cells enhances the binding and chemotactic step of T lymphocyte emigration. Clin. Exp. Immunol. 73:1988;250.
52. Fortun A., Khalil A., Gagné D., Jay-Gerin J.P., Lesur O., Fülöp T. Jr. Study of the effect of oxydatively modified low density lipoprotein on human T lymphocytes. Atherosclerosis. 134:1997;279.
53. Alcouffe J., Caspar-Bauguil S., Garcia V., Salvayre R., Thomsen M., Benoist H. Oxidized low density lipoproteins induce apoptosis in PHA-activated peripheral blood mononuclear cells and in Jurkat T-cell line. J. Lipid Res. 40:1999;1200.
54. Crispe I.N. Death and destruction of activated T lymphocytes. Immunol. Res. 19:1999;143.
55. Watanabe T., Shimokama T., Haraoka S., Kishikawa H. T lymphocytes in atherosclerotic lesions. Ann. NY Acad. Sci. 748:1995;40.
56. Lee K.C., Wong M., Spitzer D. Chloroquine as a probe for antigen processing by accessory cells. Transplantation. 34:1982;150.
57. June C.H., Bluestone J.A., Nadler J.M., Thompson C.B. The B7 and CD28 receptor families. Immunol. Today. 15:1994;321.
58. Lenshow D.J., Sperling A.L., Cooke M.P., Freeman G., Rhee L., Decker D.C., Gray G., Nadler L.M., Goodnow C.C., Bluestone J.A. Differential up-regulation of the B7.1 and B7.2 costimulatory molecules following immunoglobulin receptor engagement by antigen. J. Immunol. 15:1994;1990.
59. Clavreul A., D'Hellencourt C.L., Montero-Menel C., Potron G., Couez D. Vitamin D differentially regulates B7.1 and B7.2 expression on human peripheral blood monocytes. Immunology. 95:1998;272.
60. Libby P., Warner S.J.C., Friedman G.B. Interleukin 1: a mitogen for human vascular smooth muscle cells that induces the release of growth-inhibitory prostanoids. J. Clin. Invest. 81:1988;487.
61. Hansson G.K., Holm J., Holm S., Fotev Z., Hedrich H.J., Fingerle J. T lymphocytes inhibit the vascular response to injury. Proc. Natl. Acad. Sci. USA. 88:1991;10530.
62. Hansson G.K., Jonasson L., Holm J., Clowes M.M., Clowes A.W. γ-Interferon regulates vascular smooth muscle proliferation and Ia antigen expression in vivo and in vitro. Circ. Res. 63:1988;712.
63. Roselaar S.E., Schonfeld G., Daugherty A. Enhanced development of atherosclerosis in cholesterol-fed rabbits by suppression of cell-mediated immunity. J. Clin. Invest. 96:1995;1389.